Average Co-Inventor Count = 5.91
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Intercell Ag (23 from 36 patents)
2. Valneva Austria Gmbh (15 from 46 patents)
3. Valneva Se (5 from 13 patents)
4. Intercell Austria Ag (2 from 2 patents)
5. Dynavax Technologies Corporation (1 from 64 patents)
45 patents:
1. 12331084 - Multivalent OspA polypeptides and methods and uses relating thereto
2. 12195501 - Mutant fragments of OspA and methods and uses relating thereto
3. 12162907 - Subunit vaccine for treatment or prevention of a respiratory tract infection
4. 12162909 - Subunit vaccine for treatment or prevention of a respiratory tract infection
5. 12018054 - Multivalent OspA polypeptides and methods and uses relating thereto
6. 12011477 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3
7. 11684669 - CpG-adjuvanted SARS-CoV-2 virus vaccine
8. 11484587 - Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3
9. 11466058 - Mutant fragments of OspA and methods and uses relating thereto
10. 11357846 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3
11. 11208439 - Mutant fragments of OspA and methods and uses relating thereto
12. 10544194 - Mutant fragments of OspA and methods and uses relating thereto
13. 9926343 - Mutant fragments of OspA and methods and uses relating thereto
14. 8986704 - Mutant fragments of OspA and methods and uses relating thereto
15. 8952135 - [object Object]